Clinical Intervention

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 41-50 of 106 total displayed.

Past content

Null Results in Brief
IGF-I, IGFBP-3, and IGF-I/IGFBP-3 Ratio: No Association with Incident Colorectal Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study

Joshua B. Max, Paul J. Limburg, Adeboye Ogunseitan, Rachael Z. Stolzenberg-Solomon, Robert A. Vierkant, Michael J. Pollak, Thomas A. Sellers, Jarmo Virtamo, James R. Cerhan, and Demetrius Albanes
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1832-1834. [Full text] [PDF]  

Research Articles: Therapeutics, Targets, and Development
Chemoprevention by perillyl alcohol coupled with viral gene therapy reduces pancreatic cancer pathogenesis

Irina V. Lebedeva, Zhao-zhong Su, Nichollaq Vozhilla, Lejuan Chatman, Devanand Sarkar, Paul Dent, Mohammad Athar, and Paul B. Fisher
Mol. Cancer Ther. 2008; 7: 2042-2050. [Abstract] [Full text] [PDF]  

Research Articles
Finasteride Does Not Increase the Risk of High-Grade Prostate Cancer: A Bias-Adjusted Modeling Approach

Mary W. Redman, Catherine M. Tangen, Phyllis J. Goodman, M. Scott Lucia, Charles A. Coltman, Jr., and Ian M. Thompson
Cancer Prevention Research first published on May 18, 2008 as doi: 10.1158/1940-6207.CAPR-08-0092. [Abstract] Online First [PDF] [ Perspective on This Article ] [ Finasteride and Prostate Cancer: New York Times Article ]  

Regular Article
Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention

M. Scott Lucia, Amy K. Darke, Phyllis J. Goodman, Francisco G. La Rosa, Howard L. Parnes, Leslie G. Ford, Charles A. Coltman, Jr., and Ian M. Thompson
Cancer Prevention Research first published on May 18, 2008 as doi: 10.1158/1940-6207.CAPR-08-0078. [Abstract] Online First [PDF] [ Perspective on This Article ] [ Finasteride and Prostate Cancer: New York Times Article ]  

Research Article
Estimating Rates of True High-Grade Disease in the Prostate Cancer Prevention Trial

Paul Pinsky, Howard Parnes, and Leslie Ford
Cancer Prevention Research first published on May 18, 2008 as doi: 10.1158/1940-6207.CAPR-07-0007. [Abstract] Online First [PDF] [ Perspective on This Article ] [ Finasteride and Prostate Cancer: New York Times Article ]  

Research Articles
Biochemical Markers for Monitoring Response to Therapy: Evidence for Higher Bone Specificity by a Novel Marker Compared with Routine Markers

Diana Julie Leeming, Axel Hegele, Inger Byrjalsen, Rainer Hofmann, Per Qvist, Morten Asser Karsdal, Andres Jan Schrader, Reinhold Wagner, and Peter Olbert
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1269-1276. [Abstract] [Full text] [PDF]  

Research Article
Difluoromethylornithine Plus Sulindac for the Prevention of Sporadic Colorectal Adenomas: A Randomized Placebo-Controlled, Double-Blind Trial

Frank L. Meyskens, Jr., Christine E. McLaren, Daniel Pelot, Sharon Fujikawa-Brooks, Philip M. Carpenter, Ernest Hawk, Gary Kelloff, Michael J. Lawson, Jayashri Kidao, John McCracken, C. Gregory Albers, Dennis J. Ahnen, D. Kim Turgeon, Steven Goldschmid, Peter Lance, Curt H. Hagedorn, Daniel L. Gillen, and Eugene W. Gerner
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-08-0042. [Abstract] Online First [PDF] [ Perspective on This Article ]  

Research Article
Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial

Nancy L. Cho, Mark Redston, Ann G. Zauber, Adelaide M. Carothers, Jason Hornick, Andrew Wilton, Stephen Sontag, Norman Nishioka, Francis M. Giardiello, John R. Saltzman, Chris Gostout, Craig J. Eagle, Ernest T. Hawk, and Monica M. Bertagnolli
Cancer Prevention Research first published on Apr 14, 2008 as doi: 10.1158/1940-6207.CAPR-07-0011. [Abstract] Online First [PDF] [ Perspective on This Article ]  

Research Articles: Therapeutics, Targets, and Development
Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes

Ronald A. Lubet, Eva Szabo, Konstantin Christov, Ann M. Bode, Marna E. Ericson, Vernon E. Steele, M. Margaret Juliana, and Clinton J. Grubbs
Mol. Cancer Ther. 2008; 7: 972-979. [Abstract] [Full text] [PDF]  

Null Results in Brief
The Ratio of Specific Polychlorinated Biphenyls as a Surrogate Biomarker of Cytochrome P4501A2 Activity—A Pharmaco-Metabonomic Study in Humans

Xibiao Ye, Edward F. Fitzgerald, Marta I. Gomez, George H. Lambert, and Matthew P. Longnecker
Cancer Epidemiol. Biomarkers Prev. 2008; 17: 1013-1015. [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11